Abdulredha A. Esmail

Kuwait City, KU, Kuwait

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications

Real-world analysis of ctDNA and other biomarkers in patients with curatively resected stage I-III biliary tract cancer.

Real-world analysis of ctDNA and other biomarkers in patients with curatively resected stage I-III biliary tract cancer.

Journal: ESMO gastrointestinal oncology
Published: August 12, 2026

Correction to: Current Status of Theranostics in West Asia: A Country-based Surveillance Study.

Correction to: Current Status of Theranostics in West Asia: A Country-based Surveillance Study.

Journal: Nuclear medicine and molecular imaging
Published: December 04, 2025

Current Status of Theranostics in West Asia: A Country-based Surveillance Study.

Current Status of Theranostics in West Asia: A Country-based Surveillance Study.

Journal: Nuclear medicine and molecular imaging
Published: January 30, 2025

Targeted radioligand therapy: physics and biology, internal dosimetry and other practical aspects during 177Lu/225Ac treatment in neuroendocrine tumors and metastatic prostate cancer.

Targeted radioligand therapy: physics and biology, internal dosimetry and other practical aspects during 177Lu/225Ac treatment in neuroendocrine tumors and metastatic prostate cancer.

Journal: Theranostics
Published: December 01, 2024

68 Ga-Trivehexin PET/CT in Metastatic Non-Small Cell Lung Cancer to the Brain.

68 Ga-Trivehexin PET/CT in Metastatic Non-Small Cell Lung Cancer to the Brain.

Journal: Clinical nuclear medicine
Published: August 27, 2024

A Prospective Evaluation of Chemokine Receptor-4 (CXCR4) Overexpression in High-grade Glioma Using 68Ga-Pentixafor (Pars-Cixafor™) PET/CT Imaging.

A Prospective Evaluation of Chemokine Receptor-4 (CXCR4) Overexpression in High-grade Glioma Using 68Ga-Pentixafor (Pars-Cixafor™) PET/CT Imaging.

Journal: Academic radiology
Published: June 27, 2024

Initial clinical experience using 68Ga-FAPI-46 PET/CT for detecting various cancer types.

Initial clinical experience using 68Ga-FAPI-46 PET/CT for detecting various cancer types.

Journal: Hellenic journal of nuclear medicine
Published: April 23, 2024

Spectrum of Metabolic and Angiogenic Imaging with 18F-FDOPA and 18F-PSMA 1007 PET/CT in the Evaluation of Recurrent Glioblastoma Multiforme.

Spectrum of Metabolic and Angiogenic Imaging with 18F-FDOPA and 18F-PSMA 1007 PET/CT in the Evaluation of Recurrent Glioblastoma Multiforme.

Journal: Nuclear medicine and molecular imaging
Published: December 31, 2023

Incremental Value of 18F-PSMA-1007 PET/CT in Detection of Metastatic Renal Cell Carcinoma to the Brain.

Incremental Value of 18F-PSMA-1007 PET/CT in Detection of Metastatic Renal Cell Carcinoma to the Brain.

Journal: Clinical nuclear medicine
Published: June 08, 2022

Case of Adult Metastatic Medulloblastoma Demonstrated on 18F-DOPA PET/CT.

Case of Adult Metastatic Medulloblastoma Demonstrated on 18F-DOPA PET/CT.

Journal: Clinical nuclear medicine
Published: January 13, 2022

18F-PSMA-1007 Uptake in Paget Disease of the Bone: An "Iron Man" Sign.

18F-PSMA-1007 Uptake in Paget Disease of the Bone: An "Iron Man" Sign.

Journal: Clinical nuclear medicine
Published: August 15, 2021

Prostate-Specific Membrane Antigen Expression in Metastatic Angiosarcoma Detected on 18F-PMSA PET/CT: A New Potential Prognostic Marker.

Prostate-Specific Membrane Antigen Expression in Metastatic Angiosarcoma Detected on 18F-PMSA PET/CT: A New Potential Prognostic Marker.

Journal: Clinical nuclear medicine
Published: June 26, 2021
Showing 1-12 of 21

Last Updated: 09/26/2026